Compass Therapeutics, Inc. (CMPX)
2.52
+0.12
(+5.00%)
USD |
NASDAQ |
Aug 25, 16:00
2.50
-0.02
(-0.79%)
After-Hours: 19:59
Compass Therapeutics EPS Diluted (Quarterly) : -0.1347 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1347 |
| March 31, 2026 | -0.0983 |
| December 31, 2025 | -0.085 |
| September 30, 2025 | -0.0845 |
| June 30, 2025 | -0.1438 |
| March 31, 2025 | -0.1203 |
| December 31, 2024 | -0.109 |
| September 30, 2024 | -0.0762 |
| June 30, 2024 | -0.095 |
| March 31, 2024 | -0.079 |
| December 31, 2023 | -0.1051 |
| September 30, 2023 | -0.0782 |
| June 30, 2023 | -0.089 |
| March 31, 2023 | -0.062 |
| December 31, 2022 | -0.10 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.1186 |
| June 30, 2022 | -0.0841 |
| March 31, 2022 | -0.071 |
| December 31, 2021 | -0.1287 |
| September 30, 2021 | -0.0968 |
| June 30, 2021 | -1.075 |
| March 31, 2021 | -0.1446 |
| December 31, 2020 | -0.161 |
| September 30, 2020 | -0.1756 |
| June 30, 2020 | -0.1066 |
| March 31, 2020 | -0.1228 |
| December 31, 2019 | -0.1269 |
| September 30, 2019 | -0.1641 |
| June 30, 2019 | -0.169 |
| March 31, 2019 | -0.2067 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Upstream Bio, Inc. | -0.7276 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.15M |
| Total Expenses (Quarterly) | 25.15M |
| Enterprise Value | 261.97M |
| Earnings Yield | -15.97% |
| Normalized Earnings Yield | -15.97 |